Ascendis Pharma
North America, California, United States, Palo Alto
Description
Ascendis Pharma built a high-value pipeline that aims to change the clinical treatment paradigms.
Investor Profile
Ascendis Pharma has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B rounds (top funding stages).
- Majority of deals are located in China.
- Strong thematic focus on Biotechnology, Life Science, Pharmaceutical.
Stage Focus
- Series A (50%)
- Series B (50%)
Country Focus
- China (100%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Life Science
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
Who does Ascendis Pharma frequently co-invest with?
'/%3e%3cpath d='m450 224.315-44.467 136.87 116.401-84.559h-143.87l116.403 84.559z' style='fill:none;stroke:%23006233;stroke-width:14.62993431;stroke-miterlimit:4;stroke-dasharray:none'/%3e%3c/svg%3e)
What are some of recent deals done by Ascendis Pharma?
Find More Investors Like Ascendis Pharma
Discover similar investors in our database and build your perfect investor list.
Need help with your fundraising strategy?Read our fundraising guides
